These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


254 related items for PubMed ID: 24190587

  • 1. Basal functioning of the hypothalamic-pituitary-adrenal (HPA) axis and psychological distress in recreational ecstasy polydrug users.
    Wetherell MA, Montgomery C.
    Psychopharmacology (Berl); 2014 Apr; 231(7):1365-75. PubMed ID: 24190587
    [Abstract] [Full Text] [Related]

  • 2. Hypothalamic-pituitary-adrenal axis responses to stress in subjects with 3,4-methylenedioxy-methamphetamine ('ecstasy') use history: correlation with dopamine receptor sensitivity.
    Gerra G, Bassignana S, Zaimovic A, Moi G, Bussandri M, Caccavari R, Brambilla F, Molina E.
    Psychiatry Res; 2003 Sep 30; 120(2):115-24. PubMed ID: 14527643
    [Abstract] [Full Text] [Related]

  • 3. Recreational ecstasy/MDMA and other drug users from the UK and Italy: psychiatric symptoms and psychobiological problems.
    Parrott AC, Milani RM, Parmar R, Turner JD.
    Psychopharmacology (Berl); 2001 Dec 30; 159(1):77-82. PubMed ID: 11797073
    [Abstract] [Full Text] [Related]

  • 4. Differences in prefrontal blood oxygenation during an acute multitasking stressor in ecstasy polydrug users.
    Roberts CA, Wetherell MA, Fisk JE, Montgomery C.
    Psychol Med; 2015 Jan 30; 45(2):395-406. PubMed ID: 25066866
    [Abstract] [Full Text] [Related]

  • 5. Psychiatric profiles of mothers who take Ecstasy/MDMA during pregnancy: reduced depression 1 year after giving birth and quitting Ecstasy.
    Turner JJ, Parrott AC, Goodwin J, Moore DG, Fulton S, Min MO, Singer LT.
    J Psychopharmacol; 2014 Jan 30; 28(1):55-61. PubMed ID: 24327452
    [Abstract] [Full Text] [Related]

  • 6. Increased cortisol levels in hair of recent Ecstasy/MDMA users.
    Parrott AC, Sands HR, Jones L, Clow A, Evans P, Downey LA, Stalder T.
    Eur Neuropsychopharmacol; 2014 Mar 30; 24(3):369-74. PubMed ID: 24333019
    [Abstract] [Full Text] [Related]

  • 7. Oxytocin, cortisol and 3,4-methylenedioxymethamphetamine: neurohormonal aspects of recreational 'ecstasy'.
    Parrott AC.
    Behav Pharmacol; 2016 Dec 30; 27(8):649-658. PubMed ID: 27681116
    [Abstract] [Full Text] [Related]

  • 8. Attributions for psychobiological changes in ecstasy/MDMA and other polydrug users.
    Soar K, Parrott A, Turner J.
    J Psychopharmacol; 2009 Sep 30; 23(7):745-58. PubMed ID: 18635698
    [Abstract] [Full Text] [Related]

  • 9. Psychobiological problems in heavy 'ecstasy' (MDMA) polydrug users.
    Parrott AC, Sisk E, Turner JJ.
    Drug Alcohol Depend; 2000 Jul 01; 60(1):105-10. PubMed ID: 10821995
    [Abstract] [Full Text] [Related]

  • 10. Depression, impulsiveness, sleep, and memory in past and present polydrug users of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy).
    Taurah L, Chandler C, Sanders G.
    Psychopharmacology (Berl); 2014 Feb 01; 231(4):737-51. PubMed ID: 24114426
    [Abstract] [Full Text] [Related]

  • 11. MDMA, cortisol, and heightened stress in recreational ecstasy users.
    Parrott AC, Montgomery C, Wetherell MA, Downey LA, Stough C, Scholey AB.
    Behav Pharmacol; 2014 Sep 01; 25(5-6):458-72. PubMed ID: 25014666
    [Abstract] [Full Text] [Related]

  • 12. Effects of ecstasy/polydrug use on memory for associative information.
    Gallagher DT, Fisk JE, Montgomery C, Judge J, Robinson SJ, Taylor PJ.
    Psychopharmacology (Berl); 2012 Aug 01; 222(4):579-91. PubMed ID: 22302139
    [Abstract] [Full Text] [Related]

  • 13. MDMA and heightened cortisol: a neurohormonal perspective on the pregnancy outcomes of mothers used 'Ecstasy' during pregnancy.
    Parrott AC, Moore DG, Turner JJ, Goodwin J, Min MO, Singer LT.
    Hum Psychopharmacol; 2014 Jan 01; 29(1):1-7. PubMed ID: 24424703
    [Abstract] [Full Text] [Related]

  • 14. Attachment impacts cortisol awakening response in chronically depressed individuals.
    Adams GC, Wrath AJ, von Dewitz B, Marciniuk K, Roesler A, Napper S.
    Psychoneuroendocrinology; 2020 Oct 01; 120():104778. PubMed ID: 32585509
    [Abstract] [Full Text] [Related]

  • 15. Neuroendocrine and subjective responses to pharmacological challenge with citalopram: a controlled study in male and female ecstasy/MDMA users.
    Allott K, Canny BK, Broadbear JH, Stepto NK, Murphy B, Redman J.
    J Psychopharmacol; 2009 Sep 01; 23(7):759-74. PubMed ID: 18562414
    [Abstract] [Full Text] [Related]

  • 16. Variability of the cortisol awakening response and morning salivary oxytocin in late adolescence.
    Van Dam JM, Garrett AJ, Schneider LA, Buisman-Pijlman FTA, Short MA, Hodyl NA, Edwards HK, Goldsworthy MR, Pitcher JB.
    J Neuroendocrinol; 2018 Nov 01; 30(11):e12645. PubMed ID: 30216577
    [Abstract] [Full Text] [Related]

  • 17. Cognitive function in ecstasy naive abstinent drug dependants and MDMA users.
    Potter A, Downey L, Stough C.
    Curr Drug Abuse Rev; 2013 Mar 01; 6(1):71-6. PubMed ID: 23259912
    [Abstract] [Full Text] [Related]

  • 18. Human ecstasy (MDMA) polydrug users have altered brain activation during semantic processing.
    Watkins TJ, Raj V, Lee J, Dietrich MS, Cao A, Blackford JU, Salomon RM, Park S, Benningfield MM, Di Iorio CR, Cowan RL.
    Psychopharmacology (Berl); 2013 May 01; 227(1):41-54. PubMed ID: 23241648
    [Abstract] [Full Text] [Related]

  • 19. Disaster-related prenatal maternal stress, and childhood HPA-axis regulation and anxiety: The QF2011 Queensland Flood Study.
    McLean MA, Simcock G, Elgbeili G, Laplante DP, Kildea S, Hurrion E, Lequertier B, Cobham VE, King S.
    Psychoneuroendocrinology; 2020 Aug 01; 118():104716. PubMed ID: 32479967
    [Abstract] [Full Text] [Related]

  • 20. Ecstasy (MDMA) and high prevalence psychiatric symptomatology: somatic anxiety symptoms are associated with polydrug, not ecstasy, use.
    Bedi G, Van Dam NT, Redman J.
    J Psychopharmacol; 2010 Feb 01; 24(2):233-40. PubMed ID: 18832429
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.